Granulomatous Inflammation

Granulomatous inflammation is a distinctive form of chronic inflammation in which activated macrophages aggregate into compact, organised collections called granulomas. The macrophages transform into epithelioid cells and often fuse into multinucleated giant cells, walling off agents that the immune system can neither degrade nor eliminate, such as certain mycobacteria, fungi, and foreign material.

Definition

Granulomatous inflammation is a pattern of chronic inflammation defined by focal aggregates of activated (epithelioid) macrophages, frequently with multinucleated giant cells and a surrounding rim of lymphocytes, that forms in response to persistent, poorly degradable, or strongly immunogenic stimuli.

Scope

The entry describes how granulomas form, their cellular composition and morphologic variants (including caseating and non-caseating types), the immunologic mechanisms that drive their assembly, and the broad categories of stimuli that elicit them. It treats granulomatous inflammation as a general-pathology pattern, not as guidance for diagnosing or managing any specific granulomatous disease.

Core questions

• What kinds of stimuli provoke granuloma formation?
• How do macrophages organise into an epithelioid granuloma?
• Why are some granulomas caseating and others not?

Key concepts

• Epithelioid macrophages
• Multinucleated giant cells
• Caseating versus non-caseating granulomas
• Foreign-body versus immune granulomas
• T-cell-mediated (delayed-type) hypersensitivity
• Walling off of persistent stimuli

Mechanisms

Granulomas form when macrophages encounter a stimulus they cannot clear and, under the influence of T-lymphocyte-derived cytokines, become activated epithelioid cells that aggregate and may fuse into giant cells. In immune (hypersensitivity-type) granulomas, antigen-specific T cells orchestrate macrophage recruitment and activation through a delayed-type response; in foreign-body granulomas, macrophages assemble around inert material without a prominent T-cell drive. The granuloma is traditionally viewed as a protective structure that sequesters persistent agents, but work in tuberculosis has shown it can also be exploited by the pathogen and can contribute to tissue damage, indicating a more complex, dynamic role (Ramakrishnan, 2012; Wynn, 2016).

Clinical relevance

Granulomatous inflammation is the histologic hallmark of conditions such as tuberculosis, sarcoidosis, certain fungal infections, and foreign-body reactions, and recognising the pattern is part of interpreting tissue pathology. This entry explains the underlying mechanisms for reference and does not provide diagnostic criteria or treatment recommendations for any disease.

Evidence & guidelines

The account draws on experimental immunology — particularly studies of the tuberculous granuloma — and on standard pathology references such as Robbins & Cotran Pathologic Basis of Disease (Kumar, Abbas, & Aster, 2021). As a basic histopathologic pattern it is not itself the subject of clinical guidelines; those belong to the specific granulomatous diseases.

History

The granuloma was recognised in nineteenth-century pathology as the characteristic lesion of tuberculosis and other persistent infections, and the term came to denote any organised aggregate of activated macrophages. Twentieth-century immunology linked granuloma formation to cell-mediated (delayed-type) hypersensitivity, and modern studies of the tuberculous granuloma have revised the older view of it as a purely host-protective wall, revealing a dynamic structure that the pathogen can also subvert (Ramakrishnan, 2012).

Debates

Is the tuberculous granuloma protective or permissive?

Long regarded as a host-protective structure that contains infection, the granuloma in tuberculosis is now understood to be dynamic and, in some settings, to favour mycobacterial persistence and dissemination, so its net role depends on the host-pathogen balance.

Key figures

• Lalita Ramakrishnan
• Thomas A. Wynn

Seminal works

• ramakrishnan-2012

Frequently asked questions

What is a granuloma?

A granuloma is a compact, organised aggregate of activated (epithelioid) macrophages, often with multinucleated giant cells and surrounding lymphocytes, that forms to wall off a persistent or poorly degradable stimulus.

What is the difference between caseating and non-caseating granulomas?

Caseating granulomas contain a centre of necrotic, cheese-like material and are characteristic of tuberculosis, whereas non-caseating granulomas lack such necrosis and are seen in conditions such as sarcoidosis and foreign-body reactions.